help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on November 13, 2003
Molecular Endocrinology, doi:10.1210/me.2003-0350
Molecular Endocrinology Vol. 0, No. 2003 200303501-
doi:10.1210/me.2003-0350
Copyright © 2003 by the Endocrine Society.
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
18/2/303    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow NURSA Molecule Pages Link
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leis, H.
Right arrow Articles by Pérez, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leis, H.
Right arrow Articles by Pérez, P.

Submitted on September 12, 2003
Accepted on November 3, 2003

Glucocorticoid Receptor counteracts tumorigenic activity of Akt in skin through interference with the phosphatidylinositol 3-kinase (PI3K) signaling pathway

Hugo Leis1, Angustias Page1, Angel Ramírez1, Ana Bravo1, Carmen Segrelles1, Jesús Paramio1, Domingo Barettino1, José L. Jorcano1, and Paloma Pérez1*

1 Instituto de Biomedicina de Valencia (IBV-CSIC) Jaime Roig 11, E-46010 Valencia (Spain); Project on Cell and Molecular Biology and Gene Therapy, CIEMAT. Av. Complutense 22, E-28040 Madrid (Spain); Department of Animal Pathology. Faculty of Veterinary Science, University of Santiago de Compostela, E-27002 Lugo (Spain); These two authors contributed equally to this work

* To whom correspondence should be addressed. E-mail: paloma.perez{at}ibv.csic.es.

The skin-targeted overexpression of the glucocorticoid receptor (GR) in transgenic mice dramatically impairs the inflammatory responses to tumor promoter agents and suppresses skin tumor development. The anti-inflammatory, rapid effects of corticosteroids are partially exerted through interference of GR with the phosphatidylinositol 3-kinase (PI3K)/Akt signaling pathway in several tissues, a highly relevant pathway in the mouse skin tumor progression process. In this work, we aimed to elucidate whether a cross-talk mechanism between GR and PI3K/Akt occurred in intact skin as well as the biological relevance of this interaction during skin tumorigenesis. We report that, in transgenic mice overexpressing the receptor, GR physically associated with p85{alpha}/PI3K in skin, resulting in decreased Akt and I{kappa}B kinase (IKK) activity. GR activation by dexamethasone (Dex) in normal mouse skin also decreased Akt activity within minutes, whereas cotreatment with the GR antagonist RU486 abolished Dex action. Indeed, GR exerted a non-genomic action since keratinocyte transfection with a transcriptionally defective receptor mutant still decreased PI3K and Akt activity. Moreover, GR coexpression greatly reduced the accelerated growth of malignant tumors and increased Akt activity induced by Akt-transfected keratinocytes, as shown by in vivo tumorigenic assays. Overall, our data strongly indicate that GR/PI3K-Akt cross-talk constitutes a major mechanism underlying the anti-tumor effect of glucocorticoids in skin.


Key words: glucocorticoid receptor • PI3K/Akt • skin • tumorigenesis • cross-talk

NURSA Molecule Pages Link:

Nuclear Receptors:   GR
Ligands:   Dexamethasone  |  RU486



This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
E. Donet, P. Bosch, A. Sanchis, P. Bayo, A. Ramirez, J. L. Cascallana, A. Bravo, and P. Perez
Transrepression Function of the Glucocorticoid Receptor Regulates Eyelid Development and Keratinocyte Proliferation but Is Not Sufficient to Prevent Skin Chronic Inflammation
Mol. Endocrinol., April 1, 2008; 22(4): 799 - 812.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
P. Bayo, A. Sanchis, A. Bravo, J. L. Cascallana, K. Buder, J. Tuckermann, G. Schutz, and P. Perez
Glucocorticoid Receptor Is Required for Skin Barrier Competence
Endocrinology, March 1, 2008; 149(3): 1377 - 1388.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
C. Segrelles, M. Moral, C. Lorz, M. Santos, J. Lu, J. L. Cascallana, M. F. Lara, S. Carbajal, A. B. Martinez-Cruz, R. Garcia-Escudero, et al.
Constitutively Active Akt Induces Ectodermal Defects and Impaired Bone Morphogenetic Protein Signaling
Mol. Biol. Cell, January 1, 2008; 19(1): 137 - 149.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
Y. Takano, K. Yamauchi, N. Hiramatsu, A. Kasai, K. Hayakawa, M. Yokouchi, J. Yao, and M. Kitamura
Recovery and maintenance of nephrin expression in cultured podocytes and identification of HGF as a repressor of nephrin
Am J Physiol Renal Physiol, May 1, 2007; 292(5): F1573 - F1582.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. L. Cascallana, A. Bravo, E. Donet, H. Leis, M. F. Lara, J. M. Paramio, J. L. Jorcano, and P. Perez
Ectoderm-Targeted Overexpression of the Glucocorticoid Receptor Induces Hypohidrotic Ectodermal Dysplasia
Endocrinology, June 1, 2005; 146(6): 2629 - 2638.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
D. Chrysis, F. Zaman, A. S. Chagin, M. Takigawa, and L. Savendahl
Dexamethasone Induces Apoptosis in Proliferative Chondrocytes through Activation of Caspases and Suppression of the Akt-Phosphatidylinositol 3'-Kinase Signaling Pathway
Endocrinology, March 1, 2005; 146(3): 1391 - 1397.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
C. Segrelles, S. Ruiz, M. Santos, J. Martinez-Palacio, M. F. Lara, and J. M. Paramio
Akt mediates an angiogenic switch in transformed keratinocytes
Carcinogenesis, July 1, 2004; 25(7): 1137 - 1147.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society